menu
    • menu

    Company profile for Grace Therapeutics

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Grace Therapeutics is a late-stage biopharmaceutical company focused on developing drug candidates for rare and orphan diseases. Our clinical assets have received Orphan Drug Designation from the FDA, granting seven years of market exclusivity in the United States upon approval. Additionally, we have robust intellectual property protection with over 40 granted and pending patents.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Grace TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    103 Carnegie Center Suite 300 Princeton, NJ 08540
    Telephone
    Telephone
    4506872262
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.gracetx.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    Global ChemShow

    Not Confirmed

    envelop Contact Supplier

    Global ChemShow

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Grace Therapeutics To Attend Craig-Hallum Alpha Select Conference
    Grace Therapeutics To Attend Craig-Hallum Alpha Select Conference

    17 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/17/3189080/0/en/Grace-Therapeutics-to-Participate-in-16th-Annual-Craig-Hallum-Alpha-Select-Conference.html

    GLOBENEWSWIRE
    17 Nov 2025
    Share Share
    Grace Therapeutics Reports Q2 2026 Financials, Updates Business
    Grace Therapeutics Reports Q2 2026 Financials, Updates Business

    13 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/13/3187283/0/en/Grace-Therapeutics-Announces-Second-Quarter-2026-Financial-Results-Provides-Business-Update.html

    GLOBENEWSWIRE
    13 Nov 2025
    Share Share
    Grace Announces Abstract Accepted for Presentation at SVIN Meet
    Grace Announces Abstract Accepted for Presentation at SVIN Meet

    11 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/11/3185406/0/en/Grace-Therapeutics-Announces-Abstract-Accepted-for-Presentation-at-Society-of-Vascular-and-Interventional-Neurology-Annual-Meeting.html

    GLOBENEWSWIRE
    11 Nov 2025
    Share Share
    Grace Therapeutics Secures $4.0M Via Warrant Exercises Post
    Grace Therapeutics Secures $4.0M Via Warrant Exercises Post

    23 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/23/3171970/0/en/Grace-Therapeutics-Secures-Approximately-4-0-Million-through-Common-Warrant-Exercises-Following-Acceptance-of-New-Drug-Application-for-GTx-104-for-formal-FDA-Review.html

    GLOBENEWSWIRE
    23 Oct 2025
    Share Share
    Grace Therapeutics Presents Pivotal Phase 3 Strive-On Trial
    Grace Therapeutics Presents Pivotal Phase 3 Strive-On Trial

    22 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/22/3153878/0/en/Grace-Therapeutics-Pivotal-Phase-3-STRIVE-ON-Safety-Trial-Presented-at-2025-Neurocritical-Care-Annual-Meeting.html

    GLOBENEWSWIRE
    22 Sep 2025
    Share Share
    Grace Therapeutics Secures 6th U.S. Patent for GTx-104
    Grace Therapeutics Secures 6th U.S. Patent for GTx-104

    18 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/18/3152407/0/en/Grace-Therapeutics-Granted-Sixth-U-S-Patent-Covering-I-V-Dosing-Regimen-for-GTx-104.html

    GLOBENEWSWIRE
    18 Sep 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search